SCHEMBL217241

SCHEMBL217241

Cc1cc(CCC(=O)c2ccc(-c3ccc(C(F)(F)F)cc3)s2)cc(C)c1OC(C(C)C(=O)O)C(C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 12/20 0.38
PPARD Q03181 12/20 0.38
MAPK11 Q15759 1/20 0.36
MAPK14 Q16539 1/20 0.36
S1PR1 P21453 2/20 0.36
S1PR3 Q99500 1/20 0.36
PPARG P37231 7/20 0.36
S1PR5 Q9H228 1/20 0.35
ERCC5 P28715 1/20 0.35
FEN1 P39748 1/20 0.35
PSEN1 P49768 1/20 0.35
PSEN2 P49810 1/20 0.35
APH1B Q8WW43 1/20 0.35
NCSTN Q92542 1/20 0.35
APH1A Q96BI3 1/20 0.35
PSENEN Q9NZ42 1/20 0.35
HSD17B2 P37059 1/20 0.34
FFAR1 O14842 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL217585 0.84 PPARA (0.50) PPARAPPARDPPARG
SCHEMBL16774833 0.81 S1PR1 (0.39) PPARAPPARDMAPK11MAPK14S1PR1
SCHEMBL218708 0.80 MAPK11 (0.43) PPARAPPARDMAPK11MAPK14S1PR1
SCHEMBL217240 0.80 PPARA (0.40) PPARAPPARDMAPK11MAPK14PPARG
SCHEMBL217242 0.79 MAPK11 (0.38) PPARAPPARDMAPK11MAPK14S1PR1
SCHEMBL217239 0.79 PPARD (0.40) PPARAPPARDMAPK11MAPK14PPARG
SCHEMBL217526 0.78 PPARA (0.51) PPARAPPARDPPARGFFAR1
SCHEMBL217914 0.76 HSD17B1 (0.47) PPARAPPARDMAPK11MAPK14PPARG
SCHEMBL217328 0.74 PPARA (0.58) PPARAPPARDPPARGERCC5FEN1
SCHEMBL217988 0.73 PPARA (0.46) PPARAPPARDPPARGERCC5FEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088819-B2 Derivatives of substituted 3-phenyl-1-(phenylthienyl)propan-1-ones and of 3-phenyl-1-(phenylfuranyl) propan-1-ones, preparation and use GENFIT (FR) 2012-01-03 US disclosed
US-20100029745-A1 DERIVATIVES OF SUBSTITUTED 3-PHENYL-1-(PHENYLTHIENYL)PROPAN-1-ONES AND OF 3-PHENYL-1-(PHENYLFURANYL) PROPAN-1-ONES, PREPARATION AND USE GENFIT (FR) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029745-A1 DERIVATIVES OF SUBSTITUTED 3-PHENYL-1-(PHENYLTHIENYL)PROPAN-1-ONES AND OF 3-PHENYL-1-(PHENYLFURANYL) PROPAN-1-ONES, PREPARATION AND USE TPP1, NAT1, PGC PPARA 16/4885PPARD 4/4885MAPK11 3023/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.